Birdwatch Note
2024-11-06 17:12:27 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
この37倍の根拠は下記で原典を見れ、治験で1万人あたり①HPVワクチン群で8.5人の死亡②対照群で7.2人が死亡、③子宮頸がんで死ぬ確率は0.23人なので①対③で37倍との噂です。 https://x.com/yuko_candida/status/1699607027960717321 この試験でもHPVワクチンと対照群(プラセボ群です、下記参照)の死亡率の差は単純なオッズ比でみてもp値0.76程で有意差とは程遠いですし(https://www.medcalc.org/calc/odds_ratio.php)、これらの死者は全て治験薬とは関係は見られず、死因が自動車事故の死までこの①や②に含まれている(下記箇所参照)という雑な噂です。 https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm#:~:text=In%20the%20overall%20 23の臨床試験のメタ解析でもHPVワクチン群とプラセボ群の間には死亡率の有意差はありません。 https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009069.pub3/full/ja
Written by 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1854130400420831461
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1854210248535687341
- noteId - 1854210248535687341
- participantId -
- noteAuthorParticipantId - 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE Participant Details
- createdAtMillis - 1730913147468
- tweetId - 1854130400420831461
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- この37倍の根拠は下記で原典を見れ、治験で1万人あたり①HPVワクチン群で8.5人の死亡②対照群で7.2人が死亡、③子宮頸がんで死ぬ確率は0.23人なので①対③で37倍との噂です。 https://x.com/yuko_candida/status/1699607027960717321 この試験でもHPVワクチンと対照群(プラセボ群です、下記参照)の死亡率の差は単純なオッズ比でみてもp値0.76程で有意差とは程遠いですし(https://www.medcalc.org/calc/odds_ratio.php)、これらの死者は全て治験薬とは関係は見られず、死因が自動車事故の死までこの①や②に含まれている(下記箇所参照)という雑な噂です。 https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm#:~:text=In%20the%20overall%20 23の臨床試験のメタ解析でもHPVワクチン群とプラセボ群の間には死亡率の有意差はありません。 https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009069.pub3/full/ja
Note Ratings
rated at | rated by | |
2024-11-06 18:45:03 -0600 | Rating Details | |
2024-11-06 18:41:11 -0600 | Rating Details | |
2024-11-06 18:32:13 -0600 | Rating Details | |
2024-11-06 18:14:40 -0600 | Rating Details | |
2024-11-06 17:11:52 -0600 | Rating Details | |
2024-11-06 16:40:02 -0600 | Rating Details | |
2024-11-06 16:32:04 -0600 | Rating Details | |
2024-11-06 16:27:37 -0600 | Rating Details | |
2024-11-06 16:09:02 -0600 | Rating Details | |
2024-11-06 15:56:33 -0600 | Rating Details | |
2024-11-06 15:07:27 -0600 | Rating Details | |
2024-11-06 14:54:53 -0600 | Rating Details | |
2024-11-06 14:47:52 -0600 | Rating Details | |
2024-11-06 14:37:00 -0600 | Rating Details | |
2024-11-06 13:49:09 -0600 | Rating Details | |
2024-11-06 13:24:17 -0600 | Rating Details | |
2024-11-06 12:45:46 -0600 | Rating Details | |
2024-11-06 12:42:53 -0600 | Rating Details | |
2024-11-06 12:33:48 -0600 | Rating Details | |
2024-11-06 12:31:57 -0600 | Rating Details | |
2024-11-06 11:53:55 -0600 | Rating Details | |
2024-11-06 11:21:10 -0600 | Rating Details | |
2024-11-08 17:32:39 -0600 | Rating Details | |
2024-11-07 12:02:33 -0600 | Rating Details | |
2024-11-07 08:45:31 -0600 | Rating Details | |
2024-11-07 06:42:38 -0600 | Rating Details | |
2024-11-07 05:40:26 -0600 | Rating Details | |
2024-11-07 04:52:27 -0600 | Rating Details | |
2024-11-07 03:04:31 -0600 | Rating Details | |
2024-11-07 02:48:28 -0600 | Rating Details | |
2024-11-07 02:31:50 -0600 | Rating Details | |
2024-11-07 02:10:16 -0600 | Rating Details | |
2024-11-07 00:13:16 -0600 | Rating Details | |
2024-11-07 00:02:50 -0600 | Rating Details | |
2024-11-06 21:29:14 -0600 | Rating Details | |
2024-11-06 21:10:37 -0600 | Rating Details | |
2024-11-06 20:46:37 -0600 | Rating Details | |
2024-11-06 20:42:41 -0600 | Rating Details | |
2024-11-06 20:30:51 -0600 | Rating Details | |
2024-11-06 20:16:47 -0600 | Rating Details | |
2024-11-06 19:58:57 -0600 | Rating Details | |
2024-11-06 19:28:46 -0600 | Rating Details | |
2024-11-06 18:24:22 -0600 | Rating Details | |
2024-11-06 17:06:08 -0600 | Rating Details | |
2024-11-06 17:05:22 -0600 | Rating Details | |
2024-11-06 17:02:29 -0600 | Rating Details | |
2024-11-06 17:00:20 -0600 | Rating Details | |
2024-11-06 16:23:52 -0600 | Rating Details | |
2024-11-06 16:09:22 -0600 | Rating Details | |
2024-11-06 16:05:55 -0600 | Rating Details | |
2024-11-06 14:42:23 -0600 | Rating Details | |
2024-11-06 14:07:09 -0600 | Rating Details | |
2024-11-06 13:25:53 -0600 | Rating Details | |
2024-11-06 13:01:28 -0600 | Rating Details | |
2024-11-06 12:43:02 -0600 | Rating Details | |
2024-11-07 08:21:43 -0600 | Rating Details | |
2024-11-07 03:24:48 -0600 | Rating Details | |
2024-11-07 00:10:00 -0600 | Rating Details | |
2024-11-06 23:53:11 -0600 | Rating Details | |
2024-11-06 23:51:32 -0600 | Rating Details | |
2024-11-06 22:00:40 -0600 | Rating Details | |
2024-11-06 20:00:28 -0600 | Rating Details | |
2024-11-06 19:35:17 -0600 | Rating Details | |
2024-11-06 19:25:02 -0600 | Rating Details | |
2024-11-06 18:55:33 -0600 | Rating Details | |
2024-11-06 17:50:32 -0600 | Rating Details | |
2024-11-06 16:58:13 -0600 | Rating Details | |
2024-11-06 16:45:54 -0600 | Rating Details | |
2024-11-06 16:38:31 -0600 | Rating Details | |
2024-11-06 16:18:15 -0600 | Rating Details | |
2024-11-06 15:57:49 -0600 | Rating Details | |
2024-11-06 15:42:38 -0600 | Rating Details | |
2024-11-06 12:45:32 -0600 | Rating Details | |
2024-11-06 12:36:42 -0600 | Rating Details | |
2024-11-06 12:03:21 -0600 | Rating Details |